Open Access life science journals of OMICS Group International are usually academic journals that encourage academic and technical study. These journals usually favour to release original works, following a systematic study and methodology. Articles published in open access life science journals of OMICS Group International are critically assessed following in-depth analysis of the research facts and figures. There is a standard format for article writing, which is available in the journalâs website. All the open access life science journals are arranged in alphabetical order, where we can directly go the particular journal by clicking on particular alphabet Journals are divided depending on category. So, we can search the particular journal by giving required category in search box or by directly going to the particular category. Good reputation and success of these journals can be attributed to the powerful editorial board which contains over 25000 eminent personalities that rapid and quick peer-review process.
Chemotherapy is the use of medicines or drugs to treat cancer. The thought of having chemotherapy frightens many people. But knowing what chemotherapy is, how it works, and what to expect can often help calm your fears. It can also give you a better sense of control over your cancer treatment.
A major obstacle to control cancer growth and metastasis in patients is the widespread inappropriate use of anticancer drugs. As increasing numbers and types of anticancer drugs has been developed, clinicians become more and more likely to misuse them in their practice. We have known that cancers are diff erent etiological diseases with the same pathologic characteristics of unlimited growths. With this type of heterogenous characters, it means responses to same anticancer drugs can be various from patient to patient even though they all develop from same organs of humans, or even represent with same histological tissues or phenotype. Owing to all these reasons, individualized cancer chemotherapy will be a future trend to improve the anticancer drug applications in clinics. In this article, we will document, review, discuss and highlight this issue.
Last date updated on April, 2021